Content Details
Written By
Reviewed By
MD (Pharma), MBBS
Last updated on:
14 Jun 2018 | 06:31 PM (IST)
Want to know more?
Read Our Editorial Policy

Bortiva 2 mg Injection

Prescription Required


Uses of Bortiva Powder for Injection

Bortiva 2 mg Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma.

Bortiva Powder for Injection side effects

  • Low blood platelets
  • Fatigue
  • Peripheral neuropathy (tingling and numbness of feet and hand)
  • Psychiatric disturbances
  • Nausea
  • Vomiting
  • Loss of appetite
  • Fever
  • Anemia (low number of red blood cells)
  • Diarrhea
  • Decreased appetite
  • Decreased white blood cell count (neutrophils)
  • Constipation

How to use Bortiva Powder for Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

How Bortiva Powder for Injection works

Bortiva 2 mg Injection is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in a number of proteins in the cancer cells leading to their death.

Bortiva Powder for Injection related warnings

Interaction with alcohol is unknown. Please consult your doctor.
Bortiva 2 mg Injection is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Bortiva 2 mg Injection is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
Do not drive unless you are feeling well.
Bortiva 2 mg Injection might cause tiredness, dizziness, fainting, or blurred vision which may affect your ability to drive.
Bortiva 2 mg Injection should be used with caution in patients with severe kidney disease. Dose adjustment of Bortiva 2 mg Injection may be needed. Please consult your doctor.
Limited information is available on the use of Bortiva 2 mg Injection in these patients.
Bortiva 2 mg Injection should be used with caution in patients with liver disease. Dose adjustment of Bortiva 2 mg Injection may be needed. Please consult your doctor.

What if you miss a dose of Bortiva Powder for Injection?

If you miss a dose of Bortiva 2 mg Injection, please consult your doctor.

Alternate Brands

For informational purposes only. Consult a doctor before taking any medicines.
Bortiva 2 mg Injection
MyZomib 2mg Injection
Mylan Pharmaceuticals Pvt Ltd
₹2552/Powder for Injection
save 80%
Bortirel Injection
Reliance Life Sciences
₹5240/Powder for Injection
save 58%

Expert Advice

  • Before taking bortezomib, consult your doctor if you have any of the following disease conditions: disease of liver, kidney, heart or infections like fever with rash or genital sores, diabetes, low number of red or white blood cells or bleeding problems.
  • Drink plenty of fluids every day during your treatment with bortezomib.
  • Tell your doctor if you are or planning to become pregnant or are breastfeeding.
  • Consult your doctor if you have signs of serious brain infection such as memory loss, trouble in thinking, difficulty with walking or loss of vision.
  • Do not drive or operate machinery after taking bortezomib as it may cause tiredness, dizziness, fainting or blurred vision.

Patient Concerns

Questions Related to Bortiva

Multiple myeloma can be cured or not
Dr. Rohan Khandelwal
Cancer Specialist
Yes, if diagnosed at the right stage
Please tell me the interpretation of the attach report, if possible. Also guide for further treatment process.
Dr. Sanjay Singh Rai
Cancer Specialist
U r having multiple myeloma
Do you have any questions related to Bortiva 2 mg Injection?


Q. Is Bortiva a chemotherapy/hormonal drug/ cytotoxic?

Bortiva is not a hormone. It is a chemotherapy/ cytotoxic drug used in the treatment of cancers including multiple myeloma and mantle cell lymphoma

Q. How does Bortiva work?

Bortiva belongs to the class of drugs called a proteasome inhibitor. It acts by blocking the action of proteasome, and affects the growth of cancerous (actively growing) cells

Q. Is Bortiva FDA approved?

Yes, Bortiva is approved by FDA

Q. Is Bortiva dialyzable?

Yes, Bortiva is dialyzable

Q. Is Bortiva toxic?

Bortiva can cause toxic effects if not given in appropriate dose although not everybody gets them

Q. Does Bortiva cause constipation?

Bortiva may cause side effects such as constipation.

Related Products

Disclaimer: 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover all possible side effects, drug interactions or warnings or alerts. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.
  1. Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1742-43.
  2. Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 958.
  3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 153-54.
  4. Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:External Link
  5. Bortezomib. Beerse Belgium: Janssen Pharmaceutica NV; [Accessed 26 Mar. 2019] (online) Available from:External Link
Manufacturer/Marketer Address
R-4, Khirki Main Road, Malviya Nagar New Delhi- 110 017, (India)
1 Powder for Injection in 1 vial